ALGS vs CE · rev $3.6M vs rev $10.28B
Aligos Therapeutics Inc (ALGS) versus Celanese Corporation (CE) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Celanese Corporation (CE) is a chemicals company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
ALGS currently screens at market cap $44.1M. CE currently screens at market cap $5.92B.
Not investment advice. Open the ALGS and CE stock pages for the full models.
Not investment advice.